Literature DB >> 31251309

A Case of Cisternal Pilocytic Astrocytoma Diagnosed with the Balanced Steady-State Free Precession Sequence for Magnetic Resonance Imaging: A Rare Cause of Subarachnoid Hemorrhage.

Taro Suzuki1, Yosuke Akamatsu1, Sotaro Oshida1, Kenta Aso1, Mitsumasa Osakabe2, Hiroshi Kashimura1.   

Abstract

OBJECTIVES: In approximately 15% of cases of spontaneous subarachnoid hemorrhage (SAH), an obvious source of bleeding cannot be identified by angiography; these are considered cases of SAH of unknown etiology. A rare case of cisternal pilocytic astrocytoma (PA) presenting with SAH is reported. The usefulness of the balanced steady-state free precession (bSSFP) sequence for magnetic resonance imaging (MRI) to detect small cisternal lesions is discussed. CASE DESCRIPTION: The case of a 73-year-old woman who developed repeated SAHs owing to a cisternal PA is presented. She experienced sudden onset of headache and vomiting, and brain computed tomography showed diffuse SAH, whereas angiography demonstrated normal vasculature. Follow-up imaging, including T1-weighted, T2-weighted, T1-weighted contrast-enhanced, and diffusion-weighted MRI, did not show any parenchymal or cisternal lesions, although computed tomography and fluid-attenuated inversion recovery MRI showed SAH in the same region. In contrast, the bSSFP sequence, taken as a different sequence on the same day, showed mixed-intensity reticular lesions in the left basal cistern, while neither hematoma nor positive findings were identified with the other sequences. Based on the radiologic finding and the repeated history of SAH, the lesions were partially removed 2 weeks after onset. Histological examination showed a PA.
CONCLUSIONS: Despite being extremely rare, a small cisternal lesion should be considered as a cause of SAH of unknown etiology. The bSSFP sequence may be useful for detecting cisternal lesions that may be missed on the routine MRI sequences.

Entities:  

Keywords:  Balanced steady-state free precession sequence; CT, Computed tomography; Cistern; MRI, Magnetic resonance imaging; PA, Pilocytic astrocytoma; Pilocytic astrocytoma; SAH, Subarachnoid hemorrhage; Subarachnoid hemorrhage; Unknown etiology; bSSFP, Balanced steady-state free precession

Year:  2018        PMID: 31251309      PMCID: PMC6580896          DOI: 10.1016/j.wnsx.2018.100003

Source DB:  PubMed          Journal:  World Neurosurg X        ISSN: 2590-1397


Introduction

Pilocytic astrocytoma (PA) is a World Health Organization grade I tumor typically seen in the pediatric population. In general, tumor-related hemorrhage is higher in high-grade glioma than in low-grade glioma. However, many studies have demonstrated that PA presents as intratumoral hemorrhage with a greater frequency than previously thought.2, 3 In addition, dissemination from the initial tumor has been observed as an atypical feature.4, 5 A rare case of cisternal PA without intraparenchymal mass formation presenting as subarachnoid hemorrhage (SAH) is described in this article. The usefulness of fast imaging with balanced steady-state free precession (bSSFP) magnetic resonance imaging (MRI) to detect the cisternal lesion in cases of SAH of unknown etiology is suggested.

Case Description

A 73-year-old woman presented with sudden onset of headache and vomiting. Brain computed tomography (CT) showed diffuse SAH (Figure 1). She had experienced SAH of unknown vascular etiology 2 years earlier and had been observed at another hospital. Six-vessel digital subtraction angiography showed no aneurysm or abnormal vascularity (Figure 2). Therefore, the patient was managed conservatively. Follow-up CT and MRI were performed 2 days after onset. CT demonstrated only residual subarachnoid hematoma in the right basal cistern (Figure 3A). On T1-weighted, T2-weighted, and T1-weighted contrast-enhanced images, no parenchymal or cisternal lesion was apparent (Figure 3B–D). Fluid-attenuated inversion recovery images showed subarachnoid hematoma at the right basal cistern, as shown on CT (Figure 3E). However, the bSSFP sequence (fast imaging employing steady-state acquisition [General Electric, Milwaukee, Wisconsin, USA]) demonstrated mixed-intensity reticular lesions in the left basal cistern, while residual subarachnoid hematoma was not demonstrated (Figure 3F). Based on this finding and the repeated history of SAH, the patient underwent open surgical inspection via a left pterional craniotomy to confirm the underlying pathology. When the proximal Sylvian cistern was opened, the grayish, soft, hemorrhagic component was observed. The tumor occupied the left basal cistern and involved the left internal carotid artery (Figure 4A) and its perforating branches (Figure 4B), although the border between the tumor and the brain parenchyma was clear. Intraoperative rapid pathology indicated no malignancy, suggesting low-grade glioma. A large part of the tumor anterior to the internal carotid artery and optic nerve, including the hemorrhagic component, was partially removed, because radical removal might have caused severe complications associated with injury of the perforating arteries (Figure 4C). Histopathological examination of the tumor showed a typical PA with a mixture of a compact fibrillary area and microcystic foci (Figure 4D). Subsequent surgical procedures were uneventful. The patient underwent no adjuvant therapy, and her subsequent course has been uneventful without any signs of deterioration to date.
Figure 1

Computed tomography on the day of admission showing diffuse subarachnoid hemorrhage.

Figure 2

Six-vessel angiogram (anteroposterior and lateral view) shows no aneurysm, arteriovenous malformation or fistula, dural sinus thrombosis, hypervascular tumor, or other vascular lesions. (A and B) right internal carotid artery, (C and D) left internal carotid artery, (E and F) right external carotid artery, (G and H) left external carotid artery, (I and J) right vertebral artery, and (K and L) left vertebral artery angiograms.

Figure 3

(A) Follow-up computed tomography (CT) scan 2 days after onset showing residual subarachnoid hematoma in the right basal cistern. Magnetic resonance imaging scan at the level of the basal cistern, obtained 2 days after onset, demonstrating no intraparenchymal lesion or cisternal lesion on axial T1-weighted noncontrast (B), T1-weighted contrast (C), T2-weighted images (D). Fluid-attenuated inversion recovery image showing residual subarachnoid hematoma, consistent with the findings of the CT scan (E). In contrast, the balanced steady-state free precession image demonstrating the mixed-intensity reticular lesions in the left basal cistern (arrow) (F).

Figure 4

Intraoperative view obtained via the left pterional approach. The tan and gelatinous tumor occupying the left basal cistern. The hemorrhagic component was seen at basal cistern (white arrow) (A). High magnification intraoperative view indicating residual tumor (black arrowheads) involving the perforating artery originating from the ICA (white arrow) (B). The tumor is partially removed, and the middle cerebral artery, internal carotid artery, and left optic nerve are visible (C). Photomicrograph showing diffusely proliferated astrocytic cells with a microcystic space. Perivascular proliferation of tumor cells (arrow) is visible. Hematoxylin-eosin stain, x 200 (D). ACA, anterior cerebral artery; CN II, optic nerve; FL, frontal lobe; ICA, internal carotid artery; MCA, middle cerebral artery; TL, temporal lobe.

Computed tomography on the day of admission showing diffuse subarachnoid hemorrhage. Six-vessel angiogram (anteroposterior and lateral view) shows no aneurysm, arteriovenous malformation or fistula, dural sinus thrombosis, hypervascular tumor, or other vascular lesions. (A and B) right internal carotid artery, (C and D) left internal carotid artery, (E and F) right external carotid artery, (G and H) left external carotid artery, (I and J) right vertebral artery, and (K and L) left vertebral artery angiograms. (A) Follow-up computed tomography (CT) scan 2 days after onset showing residual subarachnoid hematoma in the right basal cistern. Magnetic resonance imaging scan at the level of the basal cistern, obtained 2 days after onset, demonstrating no intraparenchymal lesion or cisternal lesion on axial T1-weighted noncontrast (B), T1-weighted contrast (C), T2-weighted images (D). Fluid-attenuated inversion recovery image showing residual subarachnoid hematoma, consistent with the findings of the CT scan (E). In contrast, the balanced steady-state free precession image demonstrating the mixed-intensity reticular lesions in the left basal cistern (arrow) (F). Intraoperative view obtained via the left pterional approach. The tan and gelatinous tumor occupying the left basal cistern. The hemorrhagic component was seen at basal cistern (white arrow) (A). High magnification intraoperative view indicating residual tumor (black arrowheads) involving the perforating artery originating from the ICA (white arrow) (B). The tumor is partially removed, and the middle cerebral artery, internal carotid artery, and left optic nerve are visible (C). Photomicrograph showing diffusely proliferated astrocytic cells with a microcystic space. Perivascular proliferation of tumor cells (arrow) is visible. Hematoxylin-eosin stain, x 200 (D). ACA, anterior cerebral artery; CN II, optic nerve; FL, frontal lobe; ICA, internal carotid artery; MCA, middle cerebral artery; TL, temporal lobe.

Discussion

Although tumor-related intraparenchymal hemorrhage was observed in between 8%–11% of PAs, a higher incidence than one would expect,3, 6 SAH is a rare presentation. Only 9 PA cases presenting with SAH, including the present case, have been reported (Table 1).2, 7, 8, 9, 10, 11, 12, 13 The median age of these patients was 30 (range 1–73) years, with a male predominance (77.8%). Except for the present case, 8 of 9 lesions (88.9%) showed mass formation on radiologic examinations, so that the lesions were detected relatively easily. The tumors were located in the hypothalamus or optic nerve in 8 of 9 cases (88.9%), with 1 case in the cerebellum. In all cases, the tumors were adjacent to the subarachnoid space, as expected. Because of its vital location and potential involvement with cranial nerves, the internal carotid artery, and its branches, total removal was not achieved in 7 of 9 cases (77.8%).
Table 1

Summary of Pilocytic Astrocytomas Presenting with Subarachnoid Hemorrhage

Series (Reference Number)Age (Years)SexMass FormationLocation of TumorOperation
Glew 1977730MaleYesHypothalamusBiopsy
Charles et al., 1981845MaleYesOptic nervePartial removal
Matsumoto et al., 1997945MaleYesHypothalamusPartial removal
Hwang et al., 19981034MaleYesHypothalamusTotal removal
Garg et al., 20041113MaleYesHypothalamusPartial removal
Lee et al., 2009121MaleYesCerebellumPartial removal
Shibahara et al., 2009218MaleYesHypothalamusBiopsy
Kato et al., 20111320FemaleYesMedial frontalTotal removal
Present case73FemaleNoBasal cisternPartial removal
Summary of Pilocytic Astrocytomas Presenting with Subarachnoid Hemorrhage Although hemorrhagic onset of PA is not as rare as was previously thought, the related mechanisms remain unclear. Pathological findings in cases of hemorrhagic PA showed nonspecific degenerative change in intratumoral vessels and no difference in proliferation of tumor and microvasculature compared to nonhemorrhagic PA.2, 3 The age distribution of patients with hemorrhagic PA tends to be older than that of patients with nonhemorrhagic PA. This older-age predominance was seen in the PA patients presenting with SAH as well. Therefore, because PAs are slow-growing tumors and might be incidentally detected in adults, degenerative changes in intratumoral vessels in long-standing PAs might be related to the onset of SAH. PAs seems to be the exception to the rule of low-grade neoplasm owing to some inconsistent aspects. PAs sometimes have a ring-enhancement pattern, which is seen in high-grade glioma, as well as the classic pattern of the cyst-like mass with an enhancing mural nodule. Furthermore, previous studies demonstrated that leptomeningeal dissemination of PAs occurs in about 2%–12% of cases, with a higher incidence if the tumors are located at the hypothalamus or chiasma. However, if the tumor does not show mass formation on routine images and the patient is asymptomatic, the lesions may be underestimated and undiagnosed, as in the present case. In the present patient, the disseminated lesion was visible only on the bSSFP sequence, not on the other routine sequences, including the postcontrast T1 sequence. The bSSFP sequence is now freely available and useful when routine MRI sequences cannot provide desired anatomic information. This sequence provides a high signal in tissues with a high signal-to-noise ratio and enables submillimeter spatial resolution, and it is effective for detecting lesions in the cisternal space, cavernous sinuses, and the ventricular system, where it is useful for detecting subtle cerebrospinal fluid-intensity lesions that may be missed on routine spin-echo sequences. Furthermore, Abele et al. reported that modification of the basic bSSFP sequence can detect even small subcentimeter internal auditory canal lesions, which have been considered by many to require gadolinium administration for detection. Buch et al. also reported the utility of the bSSFP sequence for small drop metastases (<3 mm) and nonenhancing metastases. In addition to these reports, we suggest that the bSSFP sequence should be performed, as well as routine sequences, in cases of SAH without obvious vascular etiology. Treatment of PAs varies depending on the location of the tumors and the clinical manifestations. Surgical removal should be performed as radical therapy if the tumors arise from a removable region. However, if the tumor involves the optic pathway, hypothalamus, or surrounding vascular structures, the treatment of PA can be divided into observation, chemotherapy, radiation therapy, and surgery. In patients who have symptoms of visual loss, endocrine disturbance, hydrocephalus, or mass effect, aggressive intervention should be considered. The main role of surgery is to confirm the histological diagnosis and decompress the mass without postoperative neurologic deterioration. The effect of radiation therapy and chemotherapy in adult PAs remains unknown given the small number of patients treated. However, for patients who have small tumors and are asymptomatic, careful observation may be considered. In the present case, evacuation of the hematoma in conjunction with conservative decompression was performed without adjuvant therapy.

Conclusions

In conclusion, cisternal lesions should be included in the differential diagnosis of SAH of unknown vascular etiology; bSSFP may be useful for detecting cisternal lesions that may be missed on the other MRI sequences. Despite being extremely rare, a small cisternal lesion should be considered as a cause of SAH of unknown etiology.
  20 in total

1.  Subarachnoid hemorrhage caused by pilocytic astrocytoma--case report.

Authors:  Koichi Kato; Yosuke Moteki; Masanori Nakagawa; Shigeru Kadoyama; Hiroshi Ujiie
Journal:  Neurol Med Chir (Tokyo)       Date:  2011       Impact factor: 1.742

Review 2.  Hemorrhagic onset of cerebellar pilocytic astrocytoma in an adult: a case report and review of the literature implying a possible relation of degenerative vascular changes to the massive intratumoral hemorrhage.

Authors:  Shunsuke Shibao; Tokuhiro Kimura; Hikaru Sasaki; Hirokazu Fujiwara; Takenori Akiyama; Mari Ueno; Satoka Shidoh; Kazunari Yoshida
Journal:  Brain Tumor Pathol       Date:  2011-10-19       Impact factor: 3.298

3.  Three-dimensional fast imaging employing steady-state acquisition magnetic resonance imaging for stereotactic radiosurgery of trigeminal neuralgia.

Authors:  Gabriela-del-Rocío Chávez Chávez; Antonio A F De Salles; Timothy D Solberg; Alessandra Pedroso; Dulce Espinoza; Pablo Villablanca
Journal:  Neurosurgery       Date:  2005-03       Impact factor: 4.654

4.  Cerebellar pilocytic astrocytoma presenting with intratumor bleeding, subarachnoid hemorrhage, and subdural hematoma.

Authors:  Chang Sub Lee; Ji Soon Huh; Ki-Bum Sim; Youn Woo Kim
Journal:  Childs Nerv Syst       Date:  2008-07-16       Impact factor: 1.475

5.  Pilomyxoid astrocytoma: expanding the imaging spectrum.

Authors:  L L Linscott; A G Osborn; S Blaser; M Castillo; R H Hewlett; N Wieselthaler; S S Chin; J Krakenes; G L Hedlund; C L Sutton
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-13       Impact factor: 3.825

6.  Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma.

Authors:  Ichiyo Shibahara; Masayuki Kanamori; Toshihiro Kumabe; Hidenori Endo; Yukihiko Sonoda; Yoshikazu Ogawa; Mika Watanabe; Teiji Tominaga
Journal:  Brain Tumor Pathol       Date:  2009-04-30       Impact factor: 3.298

Review 7.  Optic pathway gliomas: a review.

Authors:  Mandy J Binning; James K Liu; John R W Kestle; Douglas L Brockmeyer; Marion L Walker
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

Review 8.  Juvenile pilocytic astrocytoma presenting with subarachnoid hemorrhage. Case report and review of the literature.

Authors:  Ajay Garg; Manish Chugh; Shailesh B Gaikwad; Sarat P Chandra; Vipul Gupta; Nalin K Mishra; Mehar Chand Sharma
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

9.  A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.

Authors:  Christoph Burkhard; Pier-Luigi Di Patre; Danielle Schüler; Georges Schüler; M Gazi Yaşargil; Yasuhiro Yonekawa; Urs M Lütolf; Paul Kleihues; Hiroko Ohgaki
Journal:  J Neurosurg       Date:  2003-06       Impact factor: 5.115

10.  Rate of spontaneous hemorrhage in histologically proven cases of pilocytic astrocytoma.

Authors:  J Bradley White; David G Piepgras; Bernd W Scheithauer; Joseph E Parisi
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.